Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study—NSGO-AVANOVA2/ENGOT-OV24.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Mansoor Raza Mirza, Elisabeth Avall-Lundqvist, Michael J. Birrer, Rene dePont Christensen, Gitte-Bettina Nyvang, Susanne Malander, Maarit Anttila, Theresa Louise Werner, Bente Lund, Gabriel Lindahl, Sakari Hietanen, Ulla Peen, Maria Dimoula, Henrik Roed, Anja Ør Knudsen, Louisa Boufercha, Synnove Staff, Anders Krog Vistisen, Line Bjørge, Johanna Unelma Maenpaa
Institutions: Copenhagen University Hospital, Rigshospitalet, Nordic Society of Gynecologic Oncology, Linköping University Hospital, University of Alabama at Birmingham, University of Southern Denmark, Odense University Hospital, Lund University, Kuopio University Hospital, University of Utah, Aalborg University Hospital, Turku University Hospital, Sahlgrenska University Hospital, Tampere University Hospital, Haukeland University Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2947682434